Works by Lee, Hans C.

Results: 68
    1

    Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 6, p. 1730, doi. 10.1111/bjh.20062
    By:
    • Pasvolsky, Oren;
    • Abid, Muhammad Bilal;
    • Milton, Denái R.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Jatoi, Asiya;
    • Khan, Hina N.;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Siddiqui, Umer;
    • Aljawai, Yosra;
    • Kebriaei, Partow;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Gaballa, Mahmoud R.;
    • Thomas, Sheeba K.
    Publication type:
    Article
    2

    Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50880-2
    By:
    • Szymura, Szymon J.;
    • Wang, Lin;
    • Zhang, Tiantian;
    • Cha, Soung-chul;
    • Song, Joo;
    • Dong, Zhenyuan;
    • Anderson, Aaron;
    • Oh, Elizabeth;
    • Lee, Vincent;
    • Wang, Zhe;
    • Parshottam, Sapna;
    • Rao, Sheetal;
    • Olsem, Jasper B.;
    • Crumpton, Brandon N.;
    • Lee, Hans C.;
    • Manasanch, Elisabet E.;
    • Neelapu, Sattva;
    • Kwak, Larry W.;
    • Thomas, Sheeba K.
    Publication type:
    Article
    3

    The Impact of Melphalan Conditioning and CD34<sup>+</sup> Cell Dose and Schedule on Post‐Transplant Outcomes in AL Amyloidosis.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 7, p. 1141, doi. 10.1002/ajh.27685
    By:
    • Muchtar, Eli;
    • Sanchorawala, Vaishali;
    • Hassan, Hamza;
    • Hegenbart, Ute;
    • Schönland, Stefan;
    • Lee, Hans C.;
    • Qazilbash, Muzaffar;
    • Kin, Andrew;
    • Zonder, Jeffrey;
    • Jacob, Eapen;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Dingli, David;
    • Arai, Sally;
    • Chin, Michelle;
    • Chakraborty, Rajshekhar;
    • Lentzsch, Suzanne;
    • Magen, Hila;
    • Shkury, Eden;
    • Sarubbi, Caitlin
    Publication type:
    Article
    4

    Single‐agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 10, p. 1571, doi. 10.1002/ajh.27029
    By:
    • Pasvolsky, Oren;
    • Milton, Denái R.;
    • Masood, Adeel;
    • Sami, Sophiya S.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Saeed, Arsalan;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.;
    • Champlin, Richard E.
    Publication type:
    Article
    5

    Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 6, p. 719, doi. 10.1002/ajh.26536
    By:
    • Sanchorawala, Vaishali;
    • Palladini, Giovanni;
    • Minnema, Monique C.;
    • Jaccard, Arnaud;
    • Lee, Hans C.;
    • Gibbs, Simon;
    • Mollee, Peter;
    • Venner, Christopher;
    • Lu, Jin;
    • Schönland, Stefan;
    • Gatt, Moshe;
    • Suzuki, Kenshi;
    • Kim, Kihyun;
    • Cibeira, María Teresa;
    • Beksac, Meral;
    • Libby, Edward;
    • Valent, Jason;
    • Hungria, Vania;
    • Wong, Sandy W.;
    • Rosenzweig, Michael
    Publication type:
    Article
    6

    Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity‐score matched analysis.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 12, p. E455, doi. 10.1002/ajh.26360
    By:
    • Patel, Romil;
    • Ma, Junsheng;
    • Bashir, Qaiser;
    • Delgado, Ruby;
    • Rondon, Gabriela;
    • Popat, Uday R.;
    • Hosing, Chitra M.;
    • Nieto, Yago;
    • Kebriaei, Partow;
    • Alousi, Amin M.;
    • Daher, May;
    • Mehta, Rohtesh;
    • Srour, Samer;
    • Weber, Donna M.;
    • Thomas, Sheeba K.;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth S.;
    • Champlin, Richard E.
    Publication type:
    Article
    7
    8
    9

    Long‐term durable efficacy of autologous stem cell transplantation in POEMS syndrome.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 3, p. E72, doi. 10.1002/ajh.25375
    By:
    • Saini, Neeraj Y.;
    • Patel, Romil D.;
    • Varma, Ankur;
    • Bashir, Qaiser;
    • Delgado, Ruby;
    • Rondon, Gabriela;
    • Popat, Uday;
    • Hosing, Chitra;
    • Nieto, Yago;
    • Kebriaei, Partow;
    • Weber, Donna M.;
    • Thomas, Sheeba K.;
    • Lee, Hans C.;
    • Manasanch, Elisabet E.;
    • Orlowski, Robert Z.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.;
    • Patel, Krina K.
    Publication type:
    Article
    10

    Melphalan‐based autologous transplant in octogenarian multiple myeloma patients.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 1, p. E2, doi. 10.1002/ajh.25310
    By:
    • Saini, Neeraj Y.;
    • Patel, Romil;
    • Varma, Ankur;
    • Bashir, Qaiser;
    • Delgado, Ruby;
    • Rondon, Gabriela;
    • Popat, Uday R.;
    • Hosing, Chitra M.;
    • Nieto, Yago;
    • Kebriaei, Partow;
    • Alousi, Amin M.;
    • Ahmed, Sairah;
    • Weber, Donna M.;
    • Thomas, Sheeba K.;
    • Lee, Hans C.;
    • Manasanch, Elisabet E.;
    • Patel, Krina K.;
    • Orlowski, Robert Z.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Article
    11

    Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01177-6
    By:
    • Ailawadhi, Sikander;
    • Lee, Hans C.;
    • Omel, James;
    • Toomey, Kathleen;
    • Hardin, James W.;
    • Gasparetto, Cristina J.;
    • Jagannath, Sundar;
    • Rifkin, Robert M.;
    • Durie, Brian G. M.;
    • Narang, Mohit;
    • Terebelo, Howard R.;
    • Joshi, Prashant;
    • Jou, Ying-Ming;
    • Mouro, Jorge;
    • Yu, Edward;
    • Abonour, Rafat
    Publication type:
    Article
    12

    Optimal infused CD34<sup>+</sup> cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01165-w
    By:
    • Pasvolsky, Oren;
    • Marcoux, Curtis;
    • Milton, Denái R.;
    • Pal, Babar;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Lee, Jaehyun;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Aljawai, Yosra;
    • Kebriaei, Partow;
    • Becnel, Melody R.;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Thomas, Sheeba K.;
    • Orlowski, Robert Z.
    Publication type:
    Article
    13

    Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
    By:
    • Pasvolsky, Oren;
    • Wang, Zhongya;
    • Milton, Denái R.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Kebriaei, Partow;
    • Aljawai, Yosra;
    • Khan, Hina N.;
    • Lee, Hans C.;
    • Ye, Christine;
    • Patel, Krina K.;
    • Thomas, Sheeba K.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.
    Publication type:
    Article
    14

    Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
    By:
    • Pasvolsky, Oren;
    • Wang, Zhongya;
    • Milton, Denái R.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Kebriaei, Partow;
    • Aljawai, Yosra;
    • Khan, Hina N.;
    • Lee, Hans C.;
    • Ye, Christine;
    • Patel, Krina K.;
    • Thomas, Sheeba K.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.
    Publication type:
    Article
    15

    Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00973-w
    By:
    • Pasvolsky, Oren;
    • Ghanem, Sassine;
    • Milton, Denái R.;
    • Rauf, Mikael;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Aljawai, Yosra;
    • Khan, Hina N.;
    • Kebriaei, Partow;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.
    Publication type:
    Article
    16

    Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
    By:
    • Pasvolsky, Oren;
    • Milton, Denái R.;
    • Rauf, Mikael;
    • Ghanem, Sassine;
    • Masood, Adeel;
    • Mohamedi, Ali H.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.
    Publication type:
    Article
    17

    Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
    By:
    • Pasvolsky, Oren;
    • Milton, Denái R.;
    • Rauf, Mikael;
    • Ghanem, Sassine;
    • Masood, Adeel;
    • Mohamedi, Ali H.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.
    Publication type:
    Article
    18
    19

    Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00432-4
    By:
    • Terpos, Evangelos;
    • Mikhael, Joseph;
    • Hajek, Roman;
    • Chari, Ajai;
    • Zweegman, Sonja;
    • Lee, Hans C.;
    • Mateos, María-Victoria;
    • Larocca, Alessandra;
    • Ramasamy, Karthik;
    • Kaiser, Martin;
    • Cook, Gordon;
    • Weisel, Katja C.;
    • Costello, Caitlin L.;
    • Elliott, Jennifer;
    • Palumbo, Antonio;
    • Usmani, Saad Z.
    Publication type:
    Article
    20

    Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 10, p. 1, doi. 10.1038/s41408-020-00369-0
    By:
    • Richardson, Paul G.;
    • Lee, Hans C.;
    • Abdallah, Al-Ola;
    • Cohen, Adam D.;
    • Kapoor, Prashant;
    • Voorhees, Peter M.;
    • Hoos, Axel;
    • Wang, Karrie;
    • Baron, January;
    • Piontek, Trisha;
    • Byrne, Julie;
    • Richmond, Scott;
    • Jewell, Roxanne C.;
    • Opalinska, Joanna;
    • Gupta, Ira;
    • Lonial, Sagar
    Publication type:
    Article
    21
    22
    23
    24

    P1279: OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA WITH TWO OR MORE HIGH‐RISK CYTOGENETIC ABNORMALITIES.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000972004.30708.e8
    By:
    • Pasvolsky, Oren;
    • Ghanem, Sassine;
    • Milton, Denái R.;
    • Masood, Adeel;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Ramdial, Jeremy L.;
    • Nieto, Yago;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Article
    25

    P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI‐CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970564.52503.e2
    By:
    • Abonour, Rafat;
    • Rifkin, Robert;
    • Ailawadhi, Sikander;
    • Lee, Hans C.;
    • Gasparetto, Christina;
    • Wagner, Lynne;
    • Durie, Brian;
    • Hardin, James;
    • Terebelo, Howard;
    • Narang, Mohit;
    • Toomey, Kathleen;
    • Tang, Yuexin;
    • Dhanasiri, Sujith;
    • Anand, Jasmeet;
    • Yu, Edward;
    • Marshall, Thomas;
    • Liu, Liang;
    • Jagannath, Sundar
    Publication type:
    Article
    26

    S197: LINKER‐MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000967700.16100.68
    By:
    • Lee, Hans C.;
    • Bumma, Naresh;
    • Richter, Joshua;
    • Dhodapkar, Madhav;
    • Hoffman, James E.;
    • Suvannasankha, Attaya;
    • Zonder, Jeffrey;
    • Shah, Mansi R.;
    • Lentzsch, Suzanne;
    • Maly, Joseph J.;
    • Ye, Jing Christine;
    • Wu, Ka Lung;
    • Deveaux, Michelle;
    • Chokshi, Dhruti;
    • Boyapati, Anita;
    • Hazra, Anasuya;
    • Lorenc, Karen Rodriguez;
    • Kroog, Glenn;
    • Houvras, Yariv;
    • Jagannath, Sundar
    Publication type:
    Article
    27
    28
    29

    P1299: OUTCOMES OF YOUNG ADULTS (AGED ≤40 YEARS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANT.

    Published in:
    2023
    By:
    • Pasvolsky, Oren;
    • Marcoux, Curtis;
    • Milton, Denái R.;
    • Masood, Adeel;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Ramdial, Jeremy L.;
    • Nieto, Yago;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Tewari, Priti;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.;
    • Crawford-Suber, Lindsay;
    • Shpall, Elizabeth J.;
    • Champlin, Richard E.
    Publication type:
    Abstract
    30
    31
    32

    Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 3, p. 710, doi. 10.1080/10428194.2021.1992763
    By:
    • Gaballa, Mahmoud R.;
    • Ma, Junsheng;
    • Tanner, Mark R.;
    • Al-Juhaishi, Taha;
    • Bashir, Qaiser;
    • Srour, Samer A.;
    • Saini, Neeraj Y.;
    • Ramdial, Jeremy L.;
    • Nieto, Yago;
    • Murphy, Regan;
    • Rezvani, Katayoun;
    • Tang, Guilin;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kaufman, Gregory P.;
    • Manasanch, Elisabet E.;
    • Ullah, Muhammad R.;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Weber, Donna M.
    Publication type:
    Article
    33

    Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 12, p. 2811, doi. 10.1080/10428194.2020.1783444
    By:
    • Hu, Bei;
    • Lin, Xiao;
    • Lee, Hans C.;
    • Huang, Xuelin;
    • Tidwell, Rebecca S. Slack;
    • Ahn, Kwang Woo;
    • Hu, Zhen-Huan;
    • Jabbour, Elias;
    • Verstovsek, Srdan;
    • Ravandi, Farhad;
    • Garcia-Manero, Guillermo;
    • Kharfan-Dabaja, Mohamed A.;
    • Hossain, Nasheed M.;
    • Marks, David I.;
    • Kamble, Rammuriti T.;
    • Inamoto, Yoshihiro;
    • Kindwall-Keller, Tamila;
    • Saad, Ayman;
    • Litzow, Mark R.;
    • Savani, Bipin N.
    Publication type:
    Article
    34

    SARS-CoV-2 in multiple myeloma: initial observation and management.

    Published in:
    2020
    By:
    • Manasanch, Elisabet E.;
    • Mulanovich, Victor;
    • Manzano, Joanna-Grace;
    • Gaeta, Maria Susan;
    • Becnel, Melody;
    • Kaufman, Gregory P.;
    • Lee, Hans C.;
    • Amini, Behrang;
    • Thomas, Sheeba K.;
    • Iyer, Swaminathan P.;
    • Weber, Donna M.;
    • Berkova, Zuzana;
    • Flowers, Christopher R.;
    • Orlowski, Robert Z.;
    • Patel, Krina K.
    Publication type:
    Letter
    35

    Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 14, p. 3536, doi. 10.1080/10428194.2019.1633633
    By:
    • Bashir, Qaiser;
    • Chamoun, Kamal;
    • Milton, Denái R.;
    • Khan, Maliha;
    • Ahmed, Sairah;
    • Mehta, Rohtesh;
    • Popat, Uday R.;
    • Kebriaei, Partow;
    • Nieto, Yago;
    • Oran, Betul;
    • Ciurea, Stefan O.;
    • Hosing, Chitra;
    • Khouri, Isa;
    • Patel, Krina;
    • Manasanch, Elisabet E.;
    • Lee, Hans C.;
    • Orlowski, Robert Z.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Article
    36

    Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 9, p. 1663, doi. 10.1002/cncr.35171
    By:
    • Pasvolsky, Oren;
    • Pasyar, Sarah;
    • Bassett, Roland L.;
    • Khan, Hina N.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Article
    37

    Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 23, p. 3746, doi. 10.1002/cncr.34987
    By:
    • Nooka, Ajay K.;
    • Cohen, Adam D.;
    • Lee, Hans C.;
    • Badros, Ashraf;
    • Suvannasankha, Attaya;
    • Callander, Natalie;
    • Abdallah, Al‐Ola;
    • Trudel, Suzanne;
    • Chari, Ajai;
    • Libby, Edward N.;
    • Chaudhry, Maria;
    • Hultcrantz, Malin;
    • Kortüm, K. Martin;
    • Popat, Rakesh;
    • Sborov, Douglas;
    • Hakim, Shawn;
    • Lewis, Eric;
    • Gorsh, Boris;
    • Bhushan, Bharat;
    • McKeown, Astrid
    Publication type:
    Article
    38

    Gastrointestinal toxicities of proteasome inhibitor therapy.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 7, p. 1, doi. 10.1007/s00432-024-05716-3
    By:
    • Shah, Jay;
    • Devalaraju, Samanthika;
    • Baerman, Elliot;
    • Lee, Irene Jeong-Ah;
    • Takigawa, Kei;
    • Machado, Antonio Pizuorno;
    • Catinis, Christine;
    • Shatila, Malek;
    • Varatharajalu, Krishnavathana;
    • Shafi, Mehnaz;
    • Lee, Hans C.;
    • Strati, Paolo;
    • Thomas, Anusha;
    • Wang, Yinghong
    Publication type:
    Article
    39

    Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 9, p. 2325, doi. 10.1007/s00277-021-04534-8
    By:
    • Davies, Faith;
    • Rifkin, Robert;
    • Costello, Caitlin;
    • Morgan, Gareth;
    • Usmani, Saad;
    • Abonour, Rafat;
    • Palumbo, Antonio;
    • Romanus, Dorothy;
    • Hajek, Roman;
    • Terpos, Evangelos;
    • Cherepanov, Dasha;
    • Stull, Dawn Marie;
    • Huang, Hui;
    • Leleu, Xavier;
    • Berdeja, Jesus;
    • Lee, Hans C.;
    • Weisel, Katja;
    • Thompson, Michael;
    • Boccadoro, Mario;
    • Zonder, Jeffrey
    Publication type:
    Article
    40

    Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia.

    Published in:
    2019
    By:
    • Saini, Neeraj Y.;
    • Patel, Romil D;
    • Varma, Ankur;
    • Bashir, Qaiser;
    • Delgado, Ruby;
    • Rondon, Gabriela;
    • Mukherjee, Akash;
    • Popat, Uday;
    • Hosing, Chitra;
    • Nieto, Yago;
    • Kebriaei, Partow;
    • Weber, Donna M.;
    • Thomas, Sheeba K.;
    • Lee, Hans C.;
    • Manasanch, Elisabet E.;
    • Orlowski, Robert Z.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.;
    • Patel, Krina K.
    Publication type:
    Letter
    41

    Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 22, p. 4198, doi. 10.1002/cncr.33809
    By:
    • Lonial, Sagar;
    • Lee, Hans C.;
    • Badros, Ashraf;
    • Trudel, Suzanne;
    • Nooka, Ajay K.;
    • Chari, Ajai;
    • Abdallah, Al‐Ola;
    • Callander, Natalie;
    • Sborov, Douglas;
    • Suvannasankha, Attaya;
    • Weisel, Katja;
    • Voorhees, Peter M.;
    • Womersley, Lynsey;
    • Baron, January;
    • Piontek, Trisha;
    • Lewis, Eric;
    • Opalinska, Joanna;
    • Gupta, Ira;
    • Cohen, Adam D.
    Publication type:
    Article
    42
    43

    Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.

    Published in:
    Cancer (0008543X), 2017, v. 123, n. 18, p. 3568, doi. 10.1002/cncr.30770
    By:
    • Veltri, Lauren W.;
    • Milton, Denái R.;
    • Delgado, Ruby;
    • Shah, Nina;
    • Patel, Krina;
    • Nieto, Yago;
    • Kebriaei, Partow;
    • Popat, Uday R.;
    • Parmar, Simrit;
    • Oran, Betul;
    • Ciurea, Stefan;
    • Hosing, Chitra;
    • Lee, Hans C.;
    • Manasanch, Elisabet;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.;
    • Bashir, Qaiser
    Publication type:
    Article
    44

    The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance.

    Published in:
    Journal of Molecular Medicine, 2020, v. 98, n. 8, p. 1161, doi. 10.1007/s00109-020-01943-6
    By:
    • Zou, Jianxuan;
    • Jones, Richard J.;
    • Wang, Hua;
    • Kuiatse, Isere;
    • Shirazi, Fazal;
    • Manasanch, Elisabet E.;
    • Lee, Hans C.;
    • Sullivan, Robert;
    • Fung, Leah;
    • Richard, Normand;
    • Erdman, Paul;
    • Torres, Eduardo;
    • Hecht, David;
    • Lam, Imelda;
    • McElwee, Brooke;
    • Chourasia, Aparajita H.;
    • Chan, Kyle W. H.;
    • Mercurio, Frank;
    • Stirling, David I.;
    • Orlowski, Robert Z.
    Publication type:
    Article
    45
    46

    Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplant.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 2, p. 763, doi. 10.1111/bjh.19937
    By:
    • Marcoux, Curtis;
    • Pasyar, Sarah;
    • Milton, Denái R.;
    • Khan, Hina N.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Neupane, Niraj;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Tang, Guilin;
    • Aljawai, Yosra;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.
    Publication type:
    Article
    47

    Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 5, p. 1944, doi. 10.1111/bjh.19384
    By:
    • Alzahrani, Kamal;
    • Pasvolsky, Oren;
    • Wang, Zhongya;
    • Milton, Denái R.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Manasanch, Elisabet E.;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.;
    • Champlin, Richard
    Publication type:
    Article
    48

    Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up‐front autologous stem cell transplant.

    Published in:
    British Journal of Haematology, 2023, v. 202, n. 4, p. 866, doi. 10.1111/bjh.18944
    By:
    • Pasvolsky, Oren;
    • Marcoux, Curtis;
    • Milton, Denái R.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Tewari, Priti;
    • Crawford‐Suber, Lindsay;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.;
    • Champlin, Richard E.
    Publication type:
    Article
    49

    Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.

    Published in:
    British Journal of Haematology, 2023, v. 201, n. 4, p. e37, doi. 10.1111/bjh.18753
    By:
    • Pasvolsky, Oren;
    • Saliba, Rima M.;
    • Masood, Adeel;
    • Mohamedi, Ali H.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Article
    50

    Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide‐based maintenance therapy.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. e23, doi. 10.1111/bjh.17393
    By:
    • Kunacheewa, Chutima;
    • Feng, Lei;
    • Manasanch, Elisabet E.;
    • Bashir, Qaiser;
    • Patel, Krina K.;
    • Mehta, Rohtesh;
    • Kaufman, Gregory P.;
    • Srour, Samer;
    • Saini, Neeraj;
    • Iyer, Swaminathan P.;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.;
    • Qazilbash, Muzaffar H.;
    • Lee, Hans C.
    Publication type:
    Article